Scheller T, Orgacka H, Szumlanski C L, Weinshilboum R M
Department of Pharmacology, Mayo Medical School/Mayo Clinic/Mayo Foundation, Rochester, MN 55905, USA.
Pharmacogenetics. 1996 Feb;6(1):43-53. doi: 10.1097/00008571-199602000-00003.
Nicotinamide N-methyltransferase (NNMT) catalyses the N-methylation of nicotinamide and other pyridines. Human liver NNMT activity shows large individual variations and a bimodal frequency distribution, raising the possibility that this activity, like those of many other methyltransferase enzymes, might be regulated by a genetic polymorphism. In an attempt to develop an experimental animal model for pharmacogenetic studies of NNMT, we determined optimal conditions for the measurement of hepatic NNMT activity in C57BL/6J mice. Mouse liver NNMT was a cytoplasmic enzyme with a pH optimum of 7.4 and apparent Km values for nicotinamide and S-adenosyl-L-methionine, cosubstrates for the reaction, of 370 and 6.5 microM, respectively. These properties were very similar to those of human liver NNMT, as was the relative sensitivity of the mouse liver enzyme to a series of methyltransferase inhibitors. Hepatic NNMT activity was then measured in tissue from male mice of 10 inbred strains. Average levels of NNMT activity in these strains varied by up to 14-fold and ranged from 1.13 +/- 0.18 U per mg protein (mean +/- SEM, n = 6) for C3H/HeJ mice to 16.0 +/- 1.16 U per mg protein in C57BR/cdJ animals. Average hepatic NNMT activities in female mice of six strains in which both sexes were studied varied from five-fold higher than those in males for "low activity' strains, to not significantly different for "high activity' strains. A series of properties of NNMT was then compared in hepatic cytosol from male mice of three different strains - one with "low' (C3H/HeJ), one with "intermediate' (DBA/2J), and one with "high' (C57BL/6J) hepatic NNMT activity. There were no striking differences among these three strains in hepatic NNMT pH optimum, substrate kinetics, IC50 values for inhibitors, thermal stability or behavior during ion exchange chromatography. The existence of large strain and gender-dependent variation in hepatic NNMT activity will make it possible to use inbred mice for studies of the role of inheritance and gender in the regulation of NNMT activity in this species, as well as for studies of the potential pharmacological and toxicological consequences of variation in this important drug-metabolizing enzyme activity.
烟酰胺N-甲基转移酶(NNMT)催化烟酰胺和其他吡啶的N-甲基化反应。人类肝脏中的NNMT活性存在较大的个体差异,且呈现双峰频率分布,这增加了一种可能性,即与许多其他甲基转移酶一样,该活性可能受基因多态性的调控。为了开发一种用于NNMT药物遗传学研究的实验动物模型,我们确定了测量C57BL/6J小鼠肝脏NNMT活性的最佳条件。小鼠肝脏NNMT是一种胞质酶,最适pH为7.4,对反应的共底物烟酰胺和S-腺苷-L-甲硫氨酸的表观Km值分别为370和6.5 microM。这些特性与人类肝脏NNMT非常相似,小鼠肝脏酶对一系列甲基转移酶抑制剂的相对敏感性也是如此。然后测定了10个近交系雄性小鼠组织中的肝脏NNMT活性。这些品系中NNMT活性的平均水平变化高达14倍,范围从C3H/HeJ小鼠的每毫克蛋白质1.13±0.18 U(平均值±标准误,n = 6)到C57BR/cdJ动物的每毫克蛋白质16.0±1.16 U。在研究了雌雄两性的6个品系的雌性小鼠中,肝脏NNMT的平均活性在“低活性”品系中比雄性高5倍,在“高活性”品系中与雄性无显著差异。然后比较了来自三种不同品系雄性小鼠肝脏胞质溶胶中NNMT的一系列特性——一种具有“低”(C3H/HeJ)肝脏NNMT活性,一种具有“中等”(DBA/2J)活性,一种具有“高”(C57BL/6J)活性。这三个品系在肝脏NNMT的最适pH、底物动力学、抑制剂的IC50值、热稳定性或离子交换色谱过程中的行为方面没有显著差异。肝脏NNMT活性存在较大的品系和性别依赖性差异,这将使得利用近交系小鼠来研究遗传和性别在该物种NNMT活性调控中的作用成为可能,也可用于研究这种重要药物代谢酶活性变化的潜在药理学和毒理学后果。